TABLE 2.

Summary of the clinicopathologic features of breast cancer studied.

Variables	Number	Ratio (%)
Clinic stage (UICC)
0	0	0
I	52	19.19
II	179	66.05
III-IV	40	14.76
Tumor size (cm)
≤2	115	42.44
>2	156	57.56
LN involvement
Negative	142	52.40
Positive	129	47.60
ER
Negative	96	35.42
Positive	175	64.58
PR
Negative	54	19.93
Positive	217	80.07
HER-2
Negative	181	66.79
Positive	90	33.21
Ki67
Negative	14	5.17
Positive	257	94.83
P53
Negative	189	69.74
Positive	82	30.26